LEI record
· United StatesDicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. in WILMINGTON — Lapsed LEI 549300CTZMJMPH28WN39, registered 2014.
Changes recorded by LEIatlas since 6 Jul 2026: updated its address on 29 Jul 2026. GLEIF publishes only the current record.
- Legal form
- Corporation
- Jurisdiction
- United States
- Registered
- 30 Jan 2014
- Next renewal
- 14 Apr 2018
Reference data
Identity
- LEI
- 549300CTZMJMPH28WN39
- ISIN
- US2530311081
- Legal form
- CorporationXTIQ
- Registration authority
- RA000602entity ID 4240086
- Legal address
- C/O THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, 19801, US
- Location
- WILMINGTON, Delaware, United States
- HQ address
- Building 1, 480 Arsenal Street, Suite 120, Watertown, US
- Initial registration
- 30 Jan 2014
- Last updated
- 28 Jul 2026
- Managing LOU (issuer)
- Bloomberg Finance L.P.5493001KJTIIGC8Y1R12
Level 2 · who owns whom
Corporate structure
Securities & codes
Securities and identifiers
- Securities (ISIN) · 1
- US2530311081
- An ISIN (ISO 6166) identifies a single security, such as a share or a bond; the LEI identifies the legal entity behind it. In GLEIF’s ISIN-to-LEI relationship file, Dicerna Pharmaceuticals, Inc. is the issuer of this ISIN. Any of them can be looked up with the ISIN lookup or directly at leiatlas.com/isin/US2530311081, which resolves to this page.
The archive · 2 versions
Change history
- 29 Jul 2026 – current
- Legal address: C/O Corporation Service Company, 2711 Centerville Road, Suite 400→C/O THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER 1209 ORANGE ST
- City: Wilmington→WILMINGTON
- 6 Jul 2026 – 29 Jul 2026First recorded version.
What this means
What the record says about Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. is a Corporation in WILMINGTON, United States with 1 ISIN-identified security mapped to its LEI, which is how regulators tie a traded instrument to the issuer behind it.
The LEI has been on record for 12 years, since 30 Jan 2014. That is about 5 years earlier than the median LEI in United States, which dates from 2019 — an early adopter by local standards.
Annual re-validation is 3130 days overdue: it fell due 14 Apr 2018. An LEI that is not re-validated lapses, which does not invalidate it but marks the reference data as unverified.
This archive holds 2 versions of the record. The most recent change was on 29 Jul 2026 and altered the legal address, city; the oldest version we hold dates from 6 Jul 2026. GLEIF publishes only the current state, so superseded values are not available from the source.
The LEI is issued and maintained by Bloomberg Finance L.P., one of the Local Operating Units accredited by GLEIF.
Beyond the LEI, 1 ISIN is mapped to this entity in the GLEIF cross-reference files.
No direct accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.
No ultimate accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.
The LEI registration is lapsed, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.
The mesh
Related entities
Source: GLEIF (CC0)Official record ↗More in United States